Characteristics of patients with heart failure and controls.

<p>ANGPTL2, angiopoietin-like protein 2; A-FABP, adipocyte fatty acid-binding protein; ACEi/ARB, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; hsCRP, high-sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LAd, left atrial dimension; LVEDd, left ventricular end-diastolic dimension; LVESd, left ventricular end-systolic dimension; LVEF, left ventricular ejection fraction; NT-proBNP, N-terminal pro-brain natriuretic peptide; TNF-α, tumor necrosis factor alpha.</p><p>* Presented with median (25^th to 75^th percentile) and analyzed by the Mann-Whitney U test</p><p># Hyperlipidemia is defined as total cholesterol ≥ 240mg/dl, triglyceride ≥ 200mg/dl, or current use of lipid-lowering medication</p><p>Characteristics of patients with heart failure and controls.